Scientific Articles and Studies-Iscador in Cancer Treatment


Articles

Absence of tumor growth stimulation in a panel of 16 human tumor cell lines by mistletoe extracts Absence of tumor growth stimulation in a panel of 16 human tumor cell lines by mistletoe extracts. By G. Maier and H.H. Fiebig

Published on 1/21/2002

Summary: The results show no evidence of stimulation of tumor growth by any of the three Iscador® preparations, comprising central nervous system, gastric, non-small cell lung, mammary, prostate, renal and uterine cancer cell lines, as well as cell lines from hematological malignancies and melanomas.

Anthroposophic Medicine in Pediatric Oncology in Germany: Results of a Population-Based Retrospective Parental Survey
Changes in Immunological Characteristics of White Blood Cells After ... Changes in Immunological Characteristics of White Blood Cells after Administration of Standardized Mistletoe Extract. By R. Klopp, W. Schmidt, W. Niemer, M. Werner, J. Beuth

Category: Cancer and Iscador

Published by in vivo 15, 2001 on 8/13/2001

Summary: After administering standardized mistletoe extract, Iscador®, the investigations showed a temporarily improved function of the microcirculation and an increased adhesion and transmigration of white blood cells in the target tissue areas. (article in 3 parts)

Changes in Immunological Characteristics of White Blood Cells after ... Part II Changes in Immunological Characteristics of White Blood Cells after Administration of Standardized Mistletoe Treatment Part II. By R. Klopp, W. Schmidt, W. Niemer, M. Werner, J. Beuth

Category: Cancer and Iscador

Published by in vivo 15, 2001 on 8/13/2001

Summary: After administering standardized mistletoe extract, Iscador®, the investigations showed a temporarily improved function of the microcirculation and an increased adhesion and transmigration of white blood cells in the target tissue areas. (article in 3 parts)

Changes in Immunological Characteristics of White Blood Cells after ... Part III Changes in Immunological Characteristics of White Blood Cells after Administration of Standardized Mistletoe Extract Part III. By R. Klopp, W. Schmidt, W. Niemer, M. Werner, J. Beuth

Category: Cancer and Iscador

Published by in vivo 15, 2001 on 8/13/2001

Summary: After administering standardized mistletoe extract, Iscador®, the investigations showed a temporarily improved function of the microcirculation and an increased adhesion and transmigration of white blood cells in the target tissue areas. (article in 3 parts)

Durable tumour responses following primary high dose induction with mistletoe extracts: Two case reports
Five-year Follow-Up of Patiens with Early Stage Breast Cancer After a Randomized Stucy Comparing Additional Tratment with Viscum Album (L.) Etract to Chemotherapy Alone
Immunological Response to Mistletoe (Viscum album L.) in Cancer Patients: A Four-Case Series
Impact of Complementary Mistletoe Extract Treatment on Quality of Life in Breast, Ovarian and Non-small Cell Lung Cancer Patients
Influence of Viscum album L (European Mistletoe) Extracts on Quality of Life in Cancer Patients A Systematic Review of Controlled Clinical Studies
Integrative Cancer Therapies
Long-term Adjuvant Treatment of Primary Intermediate to High-Risk Malignant Melanoma Long-term Adjuvant Treatment of Primary Intermediate to High-Risk Malignant Melanoma. By Matthias Augustin et al.

Category: Cancer and Iscador

Published by Arzneim.-Forsch./Drug Research on 1/1/2005

Summary: A long-term Iscador treatment in patients with mean- to high-risk primary malignant melanoma appears to be safe. A tumor enhancement was not observed. In comparison with an untreated parallel control group from the same cohort the results of the mistletoe treatment show a significant survival advantage in the UICC-/AJCC stages II-III.

Mistletoe Complementary Treatment in Patients with Primary Non-metastatic Breast Cancer Mistletoe Complementary Treatment in Patients with Primary Non-metastatic Breast Cancer. By Paul R. Bock et al.

Category: Cancer and Iscador

Published by `Arzneim.-Forsch./Drug Research' on 10/1/2004

Summary: The results of the present study confirmed the safety of the complementary therapy for patients with primary, non-metastatic mammary carcinoma with Iscador ® and showed considerably fewer ADRs attributed to concurrent conventional therapy, as well as reduced disease and treatment-associated symptoms, and suggested a prolonged overall survival in the Iscador ® group as compared with controls.

Mistletoe for Pancreatic Cancer Treatment
Mistletoe Improves Tolerability of Breast Cancer Treatment Mistletoe improves tolerability of breast cancer treatment. By Nancy Walsh

Published by FAMILY PRACTICE NEWS on 2/1/2003

Summary: Multicenter Cohort Study. Adjuvant treatment with mistletoe extract can increase the tolerability of conventional cancer treatment, improve patient quality of life, and lengthen tumor free survival, Dr. Paul R. Bock reported.

Mistletoe in Cancer: A Systematic Review on Controlled Clinical Trials
Mistletoe Therapy Dr. med. Gunver S. Kienle and Biologist Annette Bopp
Mistletoe Therapy for Cancer Patients A thesis submitted to The University of Birmingham for the degree of Master of Science in Clinical Oncology 168 pages

Mistletoe Therapy Found to be Effective for Treatment of Cancer
Mistletoe treatment in cancer-related fatigue
New Iscador® Prescribing Recommendations
Quality of Life and Neutropenia in Patients with Early Stage Breast Cancer: A Randomized Pilot Study Comparing Additional Treatment with Mistletow Extract to Chemotherapy Alone
Review Article: Influence of Viscum album L (European Mistletoe) Extracts on Quality of Life in Cancer Patients: A Systematic Review of Controlled Clinical Studies
Study of Mistletoe Treatment for Colorectal Cancer
Summary of Multicenter Open Labeled Clinical Study in Advanced Breast Cancer Patients In an open multicenter study(1) involving 9 oncological centers in Egypt, the effect of Viscum fraxini 2®(2) was investigated in 26 breast cancer patients with advanced illness. The study was conducted by Mahfouz et al. in collaboration with H. Werner, A. Scheffler of the Carl Gustav Carus Institut and I. Abouleuísh of Atos Pharmaceuticals (Sekem), Cairo.
Supportive Care in Pancreatic Carcinoma UICC Stages I-IV Patients treated with Iscador
Survival of cancer patients treated with mistletoe extract (Iscador)
Treatment of Cancer with Iscar® - 160 Frequently Asked Questions and Answers
Treatment with Iscador, Patients with Primary Non-Metastatic Colorectal Carcinoma
Two Studies of Iscador
Use of Iscador®, an Extract of European Mistletoe (Viscum Album), in Cancer Treatment Use of Iscador®, an Extract of European Mistletoe (Viscum Album), in Cancer Treatment. By R. G.-Maticek, Prof Dr med, H. Kiene, Dr med, S. M. Baumgartner, Dr sc nat, R. Ziegler, Dr rer nat

Category: Cancer and Iscador

Published by Alternative Therapies, May/June, Vol. 7, no.3 on 5/1/2001

Summary: A major 30-year-long study with more than 35,000 participants reports that extract of mistletoe (Iscador®) greatly improves survival rate for a wide variety of cancers, including breast cancer. Study participants who augmented conventional therapy with mistletoe extract survived 40% longer compared with those who didn’t use the plant therapy.

Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical research
 

Dynamic Content Management by ContentTrakker